---
$id: https://graph.org.ai/products/commodity/51113204
$type: Product
source: UNSPSC
code: "51113204"
title: "Meturedepa"
class: "51113200"
classTitle: "Alkylating agent aziridines"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Meturedepa

**UNSPSC Code**: 51113204
**Class**: [Alkylating agent aziridines](Alkylating agent aziridines.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an ethylenimine compound with the molecular formula C11H22N3O3P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 43255365IF, chemically known as ethyl n-(bis(2,2-dimethylethylenimido)phosphoro)carbamate but more generally known as meturedepa, which bears US NIH Compound Identifier 15456. European Medicines Agency schedules Meturedepa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08923MIG. The term METUREDEPA is an International Non-Proprietary Name. METUREDEPA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule meturedepa under HS 29339990 and SITC 51577. As of Q4 2014, METUREDEPA remains US FDA's Preferred Term for this commodity. Meturedepa bears US NLM identifiers UMLS ID C0609940 and NCI Concept Code C1760. SMILES: CCOC(=O)NP(=O)(N1CC1(C)C)N2CC2(C)C.

